alexa Abstract | Gene Therapy In Hypertension

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


Gene therapy is emerging out as an important trend in the pathophysiology and treatment of hypertension. Several gene targets have been identified in recent years. They include rennin, angiotensin converting enzyme, anglotensin receptors, kallikrein, endothelin, nitric oxide, adrenomedullin, glucocorticoid- suppressible hyperaldosteronism and several peptides including atrial natriuretic factor. Clinically, there are several problems before gene therapy is actually available. Once gene therapy becomes a reality, it will be a significant break through in the field of treatment of hypertension.

To read the full article Peer-reviewed Article PDF image

Author(s): Rajeshri G Karki Anita A Mehta R K Goyal

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version